INCY
Incyte Corporation · Healthcare
President, Global Head of R&D Pablo J Cagnoni sold $1.4M of Incyte Corporation
Sold$1,356,174
$125.56Price
10,801Shares
−6%Stake
What INCY did after the filing
- The stock from Fri, Aug 21 open, $126.45
- −9.7%
- S&P 500, same days
- +1.1%
Measured over 30 trading days, to the Oct 5 close.
Traded Wed, Aug 19. Filed Thu, Aug 20, 5:15 PM ET, after the close. Returns use the Aug 21 open and the Oct 5 close. Not investment advice.